• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    OncoMed Pharmaceuticals, Inc. (OMED)

    -NasdaqGS
    22.99 Up 0.16(0.70%) May 22, 4:00PM EDT
    Add to Portfolio
    Prev Close:22.83
    Open:22.85
    Bid:N/A
    Ask:29.99 x 100
    1y Target Est:40.00
    Beta:1.637
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:22.59 - 23.43
    52wk Range:16.57 - 29.83
    Volume:84,607
    Avg Vol (3m):146,711
    Market Cap:690.12M
    P/E (ttm):N/A
    EPS (ttm):-1.70
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    OMEDUp 0.70%690.12M
    STMLDown 1.51%233.69M
    VSTMUp 2.97%311.73M

    Key Statistics

    Forward P/E (1 yr):33.81
    P/S (ttm):15.85
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.93
    Quarterly EPS Est (Jun-15) :-0.43
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    OncoMed Pharmaceuticals, Inc., a clinical development-stage biotechnology company, discovers and develops protein therapeutics targeting cancer stem cells (CSCs). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback